We strive for supporting your translational research.
From biomarker discovery, high-throughput metabolic screening to the optimization and development of novel laboratory assays. Our Research Division has profound experience to support your research activities with cutting-edge technologies.
Stay in touch with us to read about our research activities, accomplishments and publications and register for our monthly ARCHIMEDlife newsletter.
We are your industrial partner with a highly experienced team and laboratory instruments for your academic research activities. We have started ARCHIMEDlife Research Institute as an initiative for “bench to bedside” medical research. We combine several strategies in translational research to advance progress from laboratory discovery to application, and final access for patients. A research process involves clinicians and researchers working together to solve health challenges faster.
Apply for a research grant? Increase your chance by collaborating with us – a service partner with a highly experienced research team and cutting-edge technologies. We have conduced successfully dozens of studies, and supported research teams worldwide with analytical services.
Several translational research projects are underway at ARCHIMEDlife Research Institute, including:
Contact, discuss and share your ideas with us: email@example.com
We have several Mass Spectrometry instruments (e.g. SCIEX 6500 QQQ, Thermo Fischer Scientific Orbitrap TM) for quantification of small molecules and discovery of novel biomarkers.
We are highly experienced in the development of novel genetic tests using state-of-the-art molecular biology methods including Next-Generation Sequencing. We support your biochemical research by genetic testing for e.g. genotype-phenotype metabolic diseases studies or tumor biology.
We offer complete laboratory services (sample management, measurement and bioinformatics) for Small Molecule and Protein Profiling.
Contact us firstname.lastname@example.org to learn more about our dozens of assays for amino acids and metabolic breakdown molecules, acylcarnitines and fatty acids, steroids, peptides and many more.
BIOCRATES Life Science Kits: We are a laboratory service partner for metabolic profiling using BIOCRATES AbsoluteIDQ® p180 Kit. This Kit quantifies up to 188 metabolites from 5 substance classes (hexose, amino acids, biogenic amines, lipids and acylcarnitines), giving the most comprehensive overview of metabolism in a single assay. It has proven to provide highly accurate and highly reproducible information on the metabolic phenotype used in diverse applications such as Cardiometabolic Diseases, Neurology, and Oncology.
Identifying relevant biomarkers is to find a needle in a haystack. Nonetheless, biomarkers become more and more important in diagnostic applications, to help to detect or to predict diseases. Biomarkers are mandatory to move towards a more personalized medicine. Highly disease-specific biomarkers hold great promise to monitor progression of disease of patients without or under therapy.
We, at ARCHIMEDlife Research Institute, put significant effort into the discovery and testing of novel biomarkers.
Contact us email@example.com to discuss your biomarker project.
Diagnostics ・R & D・Technologies
on 02 Sep, 2020
α-Mannosidosis is an inherited lysosomal storage disorder caused by genetic mutations leading to limited or no expression of a gene responsible for metabolizing oligosaccharides. Although α-Mannosidosis is considered to be ultra-rare, studies...Read More
on 18 Aug, 2020
Fabry disease (FD) is a X-linked inherited disorder where deficiency of the α-Galactosidase A (α-Gal A) enzyme causes Globotriaosylceramide (GL-3/Gb3) lipid accumulation in the cells of different organs. Due to random X-chromosome...Read More
on 18 Feb, 2020
Early diagnosis of hemoglobin disorders and Thalassemias are become more important due to a high carrier frequency and ease of global migration. In a prospective study of over 5,000 samples, we investigated...Read More
on 14 Mar, 2018
Our awarded work (Poster Finalist at MSACL Europe, also see the PDF Poster Hemoglobinopathies_MSACL) on hemoglobinopathies and thalassemias is now starting into a prospective study in cooperation with the University Medical Center Hamburg-Eppendorf,...Read More
on 07 Mar, 2018
Introduction: Methods: Results: Conclusion: Authors / corresponding author* JAlbinaNowakaSarah H.HailebDavid C.KaspercThomas P.MechtlercAndreas J.FlammeraPierre A.KrayenbuehldDaniel P.Franzena University Hospital Zurich, Zurich, Switzerland b University Zurich, Zurich, Switzerland c ARCHIMED Life Science, Vienna, Austria...Read More
on 13 Nov, 2017
Introduction: Diagnosis of neonatal sepsis remains a major challenge in neonatology. Most molecularbased methods are not customized for neonatal requirements. The aim of the present study was to assess the diagnostic accuracy...Read More
on 22 Sep, 2017
Background: While there is a proven association of upper genital tract Ureaplasma infection during pregnancy with adverse pregnancy outcome, the effect of vaginal Ureaplasma colonization on preterm delivery has been controversially debated....Read More
on 13 Sep, 2017
We are proud to be a regular part of MSACL – this year in Salzburg from 10.- 14. September 2017. Together with many other leading academic and industrial experts we explore and...Read More
on 25 Jul, 2017
An updated Consensus Guideline by worldwide experts is now available: See the publication of CLSI document NBS04-Ed2, Newborn Screening by Tandem Mass Spectrometry. The document is now available by the Clinical & Laboratory...Read More